Yes of course your right. So if Clinval does do the BB then this would be unlikely to have any short-term positive impact, and those with short-termism would be somewhat disappointed in not seeing the SP climb. (Have to remind myself not to fall into that perspective.)
So any talk of a BB has to take a more long-term view on the why to do it and evaluate the benefits and risks based on that longish-term forecasting of evolving conditions in the market.
Ann: 2025 American Academy of Dermatology Annual Meeting, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.43 |
Change
-0.540(4.16%) |
Mkt cap ! $623.0M | |||
| Open | High | Low | Value | Volume |
| $13.02 | $13.18 | $12.26 | $1.408M | 112.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 688 | $12.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.45 | 3234 | 2 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| CUV (ASX) Chart |